Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
A Phase 2 trial evaluating leriglitazone, Minoryx Therapeutics‘ investigational oral therapy for boys with cerebral adrenoleukodystrophy (CALD), has dosed its first patient at Hospital Sant Joan de Déu in Spain, the company ... Read more
SwanBio Therapeutics announced that it raised $52 million to help advance its viral-based gene therapy for adult-onset adrenoleukodystrophy (ALD) in studies essential for clinical testing, and to expand the company’s portfolio ... Read more
Bluebird Bio remains on track to submit an application to the European Medicines Agency (EMA), requesting the approval of Lenti-D for boys with cerebral adrenoleukodystrophy (CALD) by year’s end. Due to ... Read more